{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:31:41Z","timestamp":1772526701500,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002641"],"award-info":[{"award-number":["82002641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272940"],"award-info":[{"award-number":["82272940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Joint Fund Project of Liaoning Province","award":["2023-MSLH-390"],"award-info":[{"award-number":["2023-MSLH-390"]}]},{"name":"the Science and Technology Program of Liaoning Province","award":["2022JH2\/20200075"],"award-info":[{"award-number":["2022JH2\/20200075"]}]},{"name":"the 345 Talent Project and Outstanding Scientific Fund of Shengjing Hospital"},{"name":"the \u201cXingliao Talents Program\u201d of Liaoning Province","award":["XLYC2008010"],"award-info":[{"award-number":["XLYC2008010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04759-y","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T17:41:46Z","timestamp":1740073306000},"page":"8121-8134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Silencing YTHDF2 Induces Apoptosis of Neuroblastoma Cells In a Cell Line\u2013Dependent Manner via Regulating the Expression of DLK1"],"prefix":"10.1007","volume":"62","author":[{"given":"Zhongyan","family":"Hua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baocheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2821-0846","authenticated-orcid":false,"given":"Zhijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"1","key":"4759_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.24659","volume":"80","author":"N Ratner","year":"2016","unstructured":"Ratner N, Brodeur GM, Dale RC, Schor NF (2016) The \u201cneuro\u201d of neuroblastoma: neuroblastoma as a neurodevelopmental disorder. Ann Neurol 80(1):13\u201323. https:\/\/doi.org\/10.1002\/ana.24659","journal-title":"Ann Neurol"},{"issue":"3","key":"4759_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1517\/14728222.2014.867946","volume":"18","author":"GM Brodeur","year":"2014","unstructured":"Brodeur GM, Iyer R, Croucher JL, Zhuang T, Higashi M, Kolla V (2014) Therapeutic targets for neuroblastomas. Expert Opin Ther Targets 18(3):277\u201392. https:\/\/doi.org\/10.1517\/14728222.2014.867946","journal-title":"Expert Opin Ther Targets"},{"key":"4759_CR3","doi-asserted-by":"publisher","first-page":"j1863","DOI":"10.1136\/bmj.j1863","volume":"357","author":"J Shohet","year":"2017","unstructured":"Shohet J, Foster J (2017) Neuroblastoma. BMJ 357:j1863. https:\/\/doi.org\/10.1136\/bmj.j1863","journal-title":"BMJ"},{"key":"4759_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnmol.2019.00009","volume":"12","author":"JI Johnsen","year":"2019","unstructured":"Johnsen JI, Dyberg C, Wickstrom M (2019) Neuroblastoma-a neural crest derived embryonal Malignancy. Front Mol Neurosci 12:9. https:\/\/doi.org\/10.3389\/fnmol.2019.00009","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"4759_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.semcancer.2006.04.005","volume":"17","author":"A Edsjo","year":"2007","unstructured":"Edsjo A, Holmquist L, Pahlman S (2007) Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin Cancer Biol 17(3):248\u201356. https:\/\/doi.org\/10.1016\/j.semcancer.2006.04.005","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"4759_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3(3):203\u201316. https:\/\/doi.org\/10.1038\/nrc1014","journal-title":"Nat Rev Cancer"},{"key":"4759_CR7","unstructured":"Neuroblastoma treatment (PDQ(R)): health professional version. In PDQ Cancer Information Summaries, Bethesda (MD), (2002)."},{"issue":"4","key":"4759_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.maturitas.2013.09.008","volume":"76","author":"WD Joo","year":"2013","unstructured":"Joo WD, Visintin I, Mor G (2013) Targeted cancer therapy\u2013are the days of systemic chemotherapy numbered? Maturitas 76(4):308\u201314. https:\/\/doi.org\/10.1016\/j.maturitas.2013.09.008","journal-title":"Maturitas"},{"issue":"2","key":"4759_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.cmet.2019.01.001","volume":"29","author":"ST Crooke","year":"2019","unstructured":"Crooke ST, Witztum JL, Bennett CF, Baker BF (2019) RNA-targeted therapeutics. Cell Metab 29(2):501. https:\/\/doi.org\/10.1016\/j.cmet.2019.01.001","journal-title":"Cell Metab"},{"issue":"4","key":"4759_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/2159-8290.CD-14-1022","volume":"5","author":"J Guarnerio","year":"2015","unstructured":"Guarnerio J, Riccardi L, Taulli R, Maeda T, Wang G, Hobbs RM, Song MS, Sportoletti P et al (2015) A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells. Cancer Discov 5(4):396\u2013409. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-1022","journal-title":"Cancer Discov"},{"issue":"5","key":"4759_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cmet.2018.02.022","volume":"27","author":"S Wust","year":"2018","unstructured":"Wust S, Drose S, Heidler J, Wittig I, Klockner I, Franko A, Bonke E, Gunther S et al (2018) Metabolic maturation during muscle stem cell differentiation is achieved by miR-1\/133a-mediated inhibition of the Dlk1-Dio3 mega gene cluster. Cell Metab 27(5):1026-1039e6. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.022","journal-title":"Cell Metab"},{"issue":"12","key":"4759_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehy188","volume":"40","author":"P Rodriguez","year":"2019","unstructured":"Rodriguez P, Sassi Y, Troncone L, Benard L, Ishikawa K, Gordon RE, Lamas S, Laborda J et al (2019) Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis. Eur Heart J 40(12):967\u2013978. https:\/\/doi.org\/10.1093\/eurheartj\/ehy188","journal-title":"Eur Heart J"},{"issue":"1","key":"4759_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2011.11.032","volume":"318","author":"A Begum","year":"2012","unstructured":"Begum A, Kim Y, Lin Q, Yun Z (2012) DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo. Cancer Lett 318(1):26\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2011.11.032","journal-title":"Cancer Lett"},{"issue":"2","key":"4759_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbrc.2016.10.041","volume":"480","author":"YS Kim","year":"2016","unstructured":"Kim YS, Kim E, Park YJ, Kim Y (2016) Retinoic acid receptor beta enhanced the anti-cancer stem cells effect of beta-carotene by down-regulating expression of delta-like 1 homologue in human neuroblastoma cells. Biochem Biophys Res Commun 480(2):254\u2013260. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.041","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4759_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13045-018-0590-8","volume":"11","author":"Y Pan","year":"2018","unstructured":"Pan Y, Ma P, Liu Y, Li W, Shu Y (2018) Multiple functions of m(6)A RNA methylation in cancer. J Hematol Oncol 11(1):48. https:\/\/doi.org\/10.1186\/s13045-018-0590-8","journal-title":"J Hematol Oncol"},{"key":"4759_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.omtn.2019.11.022","volume":"19","author":"W Zhao","year":"2020","unstructured":"Zhao W, Qi X, Liu L, Ma S, Liu J, Wu J (2020) Epigenetic regulation of m(6)A modifications in human cancer. Mol Ther Nucleic Acids 19:405\u2013412. https:\/\/doi.org\/10.1016\/j.omtn.2019.11.022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"4759_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"XY Chen","year":"2019","unstructured":"Chen XY, Zhang J, Zhu JS (2019) The role of m(6)A RNA methylation in human cancer. Mol Cancer 18(1):103. https:\/\/doi.org\/10.1186\/s12943-019-1033-z","journal-title":"Mol Cancer"},{"issue":"7","key":"4759_CR18","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, Huttelmaier S, Liu T (2019) The critical role of RNA m(6)A methylation in cancer. Cancer Res 79(7):1285\u20131292. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2965","journal-title":"Cancer Res"},{"issue":"9","key":"4759_CR19","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1093\/nar\/gkz157","volume":"47","author":"M Zhuang","year":"2019","unstructured":"Zhuang M, Li X, Zhu J, Zhang J, Niu F, Liang F, Chen M, Li D et al (2019) The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression. Nucleic Acids Res 47(9):4765\u20134777. https:\/\/doi.org\/10.1093\/nar\/gkz157","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4759_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41422-018-0072-0","volume":"28","author":"Z Li","year":"2018","unstructured":"Li Z, Qian P, Shao W, Shi H, He XC, Gogol M, Yu Z, Wang Y et al (2018) Suppression of m(6)A reader Ythdf2 promotes hematopoietic stem cell expansion. Cell Res 28(9):904\u2013917. https:\/\/doi.org\/10.1038\/s41422-018-0072-0","journal-title":"Cell Res"},{"issue":"10","key":"4759_CR21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41422-018-0083-x","volume":"28","author":"Z Li","year":"2018","unstructured":"Li Z, Qian P, Shao W, Shi H, He XC, Gogol M, Yu Z, Wang Y et al (2018) Author correction: suppression of m(6)A reader Ythdf2 promotes hematopoietic stem cell expansion. Cell Res 28(10):1042. https:\/\/doi.org\/10.1038\/s41422-018-0083-x","journal-title":"Cell Res"},{"issue":"1","key":"4759_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","volume":"25","author":"J Paris","year":"2019","unstructured":"Paris J, Morgan M, Campos J, Spencer GJ, Shmakova A, Ivanova I, Mapperley C, Lawson H et al (2019) Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell 25(1):137-148e6. https:\/\/doi.org\/10.1016\/j.stem.2019.03.021","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4759_CR23","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1038\/s41467-018-06898-4","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang Y, Li J, Sheng R et al (2018) Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun 9(1):4772. https:\/\/doi.org\/10.1038\/s41467-018-06898-4","journal-title":"Nat Commun"},{"issue":"12","key":"4759_CR24","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1002\/jcb.26090","volume":"118","author":"SS Kotapalli","year":"2017","unstructured":"Kotapalli SS, Dasari C, Duscharla D, Kami Reddy KR, Kasula M, Ummanni R (2017) All-trans-retinoic acid stimulates overexpression of tumor protein D52 (TPD52, Isoform 3) and Neuronal differentiation of IMR-32 cells. J Cell Biochem 118(12):4358\u20134369. https:\/\/doi.org\/10.1002\/jcb.26090","journal-title":"J Cell Biochem"},{"issue":"6001","key":"4759_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/313404a0","volume":"313","author":"CJ Thiele","year":"1985","unstructured":"Thiele CJ, Reynolds CP, Israel MA (1985) Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313(6001):404\u20136. https:\/\/doi.org\/10.1038\/313404a0","journal-title":"Nature"},{"issue":"7","key":"4759_CR26","doi-asserted-by":"publisher","first-page":"e0131467","DOI":"10.1371\/journal.pone.0131467","volume":"10","author":"P Muller","year":"2015","unstructured":"Muller P, Doliva R, Busch M, Philippeit C, Stephan H, Dunker N (2015) Additive effects of retinoic acid (RA) and bone morphogenetic protein 4 (BMP-4) apoptosis signaling in retinoblastoma cell lines. PLoS One 10(7):e0131467. https:\/\/doi.org\/10.1371\/journal.pone.0131467","journal-title":"PLoS One"},{"key":"4759_CR27","doi-asserted-by":"publisher","unstructured":"Bayeva N, Coll E, Piskareva O (2021) Differentiating neuroblastoma: a systematic review of the retinoic acid, its derivatives, and synergistic interactions. J Pers Med 11 (3). https:\/\/doi.org\/10.3390\/jpm11030211","DOI":"10.3390\/jpm11030211"},{"issue":"4","key":"4759_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/nat.2019.0831","volume":"30","author":"R Maeshima","year":"2020","unstructured":"Maeshima R, Moulding D, Stoker AW, Hart SL (2020) MYCN silencing by RNAi induces neurogenesis and suppresses proliferation in models of neuroblastoma with resistance to retinoic acid. Nucleic Acid Ther 30(4):237\u2013248. https:\/\/doi.org\/10.1089\/nat.2019.0831","journal-title":"Nucleic Acid Ther"},{"issue":"3","key":"4759_CR29","doi-asserted-by":"publisher","first-page":"e58813","DOI":"10.1371\/journal.pone.0058813","volume":"8","author":"JR Farmer","year":"2013","unstructured":"Farmer JR, Altschaefl KM, O\u2019Shea KS, Miller DJ (2013) Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation. PLoS One 8(3):e58813. https:\/\/doi.org\/10.1371\/journal.pone.0058813","journal-title":"PLoS One"},{"issue":"12","key":"4759_CR30","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.4049\/jimmunol.0904133","volume":"184","author":"DC Peltier","year":"2010","unstructured":"Peltier DC, Simms A, Farmer JR, Miller DJ (2010) Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J Immunol 184(12):7010\u201321. https:\/\/doi.org\/10.4049\/jimmunol.0904133","journal-title":"J Immunol"},{"issue":"19","key":"4759_CR31","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-16-3144","volume":"77","author":"S Tsubota","year":"2017","unstructured":"Tsubota S, Kishida S, Shimamura T, Ohira M, Yamashita S, Cao D, Kiyonari S, Ushijima T et al (2017) PRC2-mediated transcriptomic alterations at the embryonic stage govern tumorigenesis and clinical outcome in MYCN-driven neuroblastoma. Cancer Res 77(19):5259\u20135271. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3144","journal-title":"Cancer Res"},{"issue":"2","key":"4759_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41390-019-0428-2","volume":"86","author":"G Carreras-Badosa","year":"2019","unstructured":"Carreras-Badosa G, Remesar X, Prats-Puig A, Xargay-Torrent S, Lizarraga-Mollinedo E, de Zegher F, Ibanez L, Bassols J et al (2019) Dlk1 expression relates to visceral fat expansion and insulin resistance in male and female rats with postnatal catch-up growth. Pediatr Res 86(2):195\u2013201. https:\/\/doi.org\/10.1038\/s41390-019-0428-2","journal-title":"Pediatr Res"},{"issue":"10","key":"4759_CR33","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/mt.2013.133","volume":"21","author":"N Chi Sabins","year":"2013","unstructured":"Chi Sabins N, Taylor JL, Fabian KP, Appleman LJ, Maranchie JK, Stolz DB, Storkus WJ (2013) DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature. Mol Ther 21(10):1958\u201368. https:\/\/doi.org\/10.1038\/mt.2013.133","journal-title":"Mol Ther"},{"issue":"11","key":"4759_CR34","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1016\/j.celrep.2019.02.046","volume":"26","author":"J Finn","year":"2019","unstructured":"Finn J, Sottoriva K, Pajcini KV, Kitajewski JK, Chen C, Zhang W, Malik AB, Liu Y (2019) Dlk1-Mediated temporal regulation of notch signaling is required for differentiation of alveolar type II to type I cells during repair. Cell Rep 26(11):2942-2954e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.046","journal-title":"Cell Rep"},{"issue":"1","key":"4759_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1158\/1541-7786.MCR-13-0360","volume":"12","author":"A Begum","year":"2014","unstructured":"Begum A, Lin Q, Yu C, Kim Y, Yun Z (2014) Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity. Mol Cancer Res 12(1):155\u201364. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0360","journal-title":"Mol Cancer Res"},{"issue":"1","key":"4759_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13287-019-1131-2","volume":"10","author":"J Huang","year":"2019","unstructured":"Huang J, Zhao X, Wang J, Cheng Y, Wu Q, Wang B, Zhao F, Meng L et al (2019) Distinct roles of Dlk1 isoforms in bi-potential differentiation of hepatic stem cells. Stem Cell Res Ther 10(1):31. https:\/\/doi.org\/10.1186\/s13287-019-1131-2","journal-title":"Stem Cell Res Ther"},{"key":"4759_CR37","doi-asserted-by":"publisher","first-page":"8523465","DOI":"10.1155\/2020\/8523465","volume":"2020","author":"P Tian","year":"2020","unstructured":"Tian P, Tao L, Wang Y, Han X (2020) MicroRNA-127 inhibits the progression of melanoma by downregulating delta-like homologue 1. Biomed Res Int 2020:8523465. https:\/\/doi.org\/10.1155\/2020\/8523465","journal-title":"Biomed Res Int"},{"issue":"2","key":"4759_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10456-018-9596-7","volume":"21","author":"CC Huang","year":"2018","unstructured":"Huang CC, Kuo HM, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC et al (2018) Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1\/Akt\/eNOS signaling in endothelial cells. Angiogenesis 21(2):299\u2013312. https:\/\/doi.org\/10.1007\/s10456-018-9596-7","journal-title":"Angiogenesis"},{"issue":"4","key":"4759_CR39","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10456-018-9615-8","volume":"21","author":"CC Huang","year":"2018","unstructured":"Huang CC, Kuo HM, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC et al (2018) Correction to: soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1\/Akt\/eNOS signaling in endothelial cells. Angiogenesis 21(4):901. https:\/\/doi.org\/10.1007\/s10456-018-9615-8","journal-title":"Angiogenesis"},{"issue":"7","key":"4759_CR40","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara S, Jaffrey SR (2020) A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA. Cell 181(7):1582-1595e18. https:\/\/doi.org\/10.1016\/j.cell.2020.05.012","journal-title":"Cell"},{"key":"4759_CR41","doi-asserted-by":"publisher","first-page":"553045","DOI":"10.3389\/fonc.2020.553045","volume":"10","author":"H Guo","year":"2020","unstructured":"Guo H, Wang B, Xu K, Nie L, Fu Y, Wang Z, Wang Q, Wang S et al (2020) m(6)A Reader HNRNPA2B1 promotes esophageal cancer progression via up-regulation of ACLY and ACC1. Front Oncol 10:553045. https:\/\/doi.org\/10.3389\/fonc.2020.553045","journal-title":"Front Oncol"},{"issue":"4","key":"4759_CR42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.03.010","volume":"31","author":"D Dixit","year":"2017","unstructured":"Dixit D, Xie Q, Rich JN, Zhao JC (2017) Messenger RNA methylation regulates glioblastoma tumorigenesis. Cancer Cell 31(4):474\u2013475. https:\/\/doi.org\/10.1016\/j.ccell.2017.03.010","journal-title":"Cancer Cell"},{"issue":"2","key":"4759_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuron.2017.12.036","volume":"97","author":"YL Weng","year":"2018","unstructured":"Weng YL, Wang X, An R, Cassin J, Vissers C, Liu Y, Liu Y, Xu T et al (2018) Epitranscriptomic m(6)A regulation of axon regeneration in the adult mammalian nervous system. Neuron 97(2):313-325e6. https:\/\/doi.org\/10.1016\/j.neuron.2017.12.036","journal-title":"Neuron"},{"issue":"3","key":"4759_CR44","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1007\/s12035-018-1138-1","volume":"56","author":"K Du","year":"2019","unstructured":"Du K, Zhang L, Lee T, Sun T (2019) m(6)A RNA methylation controls neural development and is involved in human diseases. Mol Neurobiol 56(3):1596\u20131606. https:\/\/doi.org\/10.1007\/s12035-018-1138-1","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4759_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-020-01735-3","volume":"39","author":"C Du","year":"2020","unstructured":"Du C, Lv C, Feng Y, Yu S (2020) Activation of the KDM5A\/miRNA-495\/YTHDF2\/m6A-MOB3B axis facilitates prostate cancer progression. J Exp Clin Cancer Res 39(1):223. https:\/\/doi.org\/10.1186\/s13046-020-01735-3","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4759_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12935-021-01807-0","volume":"21","author":"JY Wang","year":"2021","unstructured":"Wang JY, Lu AQ (2021) The biological function of m6A reader YTHDF2 and its role in human disease. Cancer Cell Int 21(1):109. https:\/\/doi.org\/10.1186\/s12935-021-01807-0","journal-title":"Cancer Cell Int"},{"issue":"6","key":"4759_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1261\/rna.073502.119","volume":"26","author":"AM Heck","year":"2020","unstructured":"Heck AM, Russo J, Wilusz J, Nishimura EO, Wilusz CJ (2020) YTHDF2 destabilizes m(6)A-modified neural-specific RNAs to restrain differentiation in induced pluripotent stem cells. RNA 26(6):739\u2013755. https:\/\/doi.org\/10.1261\/rna.073502.119","journal-title":"RNA"},{"issue":"12","key":"4759_CR48","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1093\/nar\/gkz312","volume":"47","author":"T Song","year":"2019","unstructured":"Song T, Yang Y, Wei H, Xie X, Lu J, Zeng Q, Peng J, Zhou Y et al (2019) Zfp217 mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to promote adipogenic differentiation. Nucleic Acids Res 47(12):6130\u20136144. https:\/\/doi.org\/10.1093\/nar\/gkz312","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4759_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13048-020-00717-5","volume":"13","author":"J Li","year":"2020","unstructured":"Li J, Wu L, Pei M, Zhang Y (2020) YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells. J Ovarian Res 13(1):111. https:\/\/doi.org\/10.1186\/s13048-020-00717-5","journal-title":"J Ovarian Res"},{"issue":"1","key":"4759_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.21037\/tp-20-168","volume":"10","author":"J Tang","year":"2021","unstructured":"Tang J, Lu H, Yang Z, Li L, Li L, Zhang J, Cheng J, Li Y et al (2021) Associations between WTAP gene polymorphisms and neuroblastoma susceptibility in Chinese children. Transl Pediatr 10(1):146\u2013152. https:\/\/doi.org\/10.21037\/tp-20-168","journal-title":"Transl Pediatr"},{"issue":"8","key":"4759_CR51","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.7150\/jca.54496","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Cheng J, Li L, Li Y, Zhou H, Zhang J, Li S, Xia H et al (2021) YTHDF1 gene polymorphisms and neuroblastoma susceptibility in Chinese children: an eight-center case-control study. J Cancer 12(8):2465\u20132471. https:\/\/doi.org\/10.7150\/jca.54496","journal-title":"J Cancer"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04759-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:03:20Z","timestamp":1751378600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04759-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4759"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04759-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}